## **Core Concept**
Seminoma is a type of testicular cancer that originates from the germ cells. It is one of the most common testicular cancers and is known for its sensitivity to radiotherapy. Tumor markers play a crucial role in the diagnosis, monitoring, and follow-up of testicular cancer.

## **Why the Correct Answer is Right**
The correct answer, **. Human chorionic gonadotropin (hCG)**, is a tumor marker that can be elevated in certain types of testicular cancer, including choriocarcinoma and some cases of seminoma, especially when there is a component of choriocarcinoma or when the tumor exhibits syncytiotrophoblastic cells. However, the more specific and commonly associated marker with seminoma is not listed here but **LDH (Lactate Dehydrogenase)** is often elevated. hCG is particularly relevant in the context of seminomas with a trophoblastic component.

## **Why Each Wrong Option is Incorrect**
- **Option A: . Carcinoembryonic antigen (CEA)**: This marker is more commonly associated with gastrointestinal and other epithelial cancers, not typically with seminomas.
- **Option B: . Alpha-fetoprotein (AFP)**: This marker is specifically elevated in non-seminomatous germ cell tumors (NSGCTs) like yolk sac tumors and some embryonal carcinomas but not typically in pure seminomas.
- **Option D: . Prostate-specific antigen (PSA)**: This marker is specific to prostate cancer and not related to testicular cancer or seminoma.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **LDH levels are often elevated in seminomas** and can serve as a prognostic marker. Additionally, seminomas typically do not elevate AFP, which helps differentiate them from non-seminomatous germ cell tumors.

## **Correct Answer: .**